This article is for physicians, primary care providers, and clinicians caring for our members
We are increasing our reimbursement for COVID-19 lab and specimen collection codes, retroactive to their effective date, in response to the Massachusetts Division of Insurance (DOI) Bulletin 2020-16, issued May 18, 2020.
We will reprocess all claims for these testing codes back to the code effective date. We’ll continue to monitor our reimbursement for these codes as new information becomes available.
This change applies to all products except Medicare Advantage.
Please refer to the Temporary Professional Commercial and FEP Fee Schedule During COVID-19 Public Health Emergency for updated reimbursement information. To view the fee schedule, log on to Provider Central, and go to Office Resources>Billing & Reimbursement>Fee Schedules.
See the COVID-19 temporary payment policy for additional information on reimbursement and billing requirements.
Questions?
Call Network Management and Credentialing Services at 1-800-316-BLUE (2583).
MPC_030620-1N-89